This study compared changes in the estimated glomerular filtration rate (eGFR) slope associated with the initiation of dotinurad (a SURI) versus febuxostat (a xanthine oxidase inhibitor) in patients with chronic kidney disease, mainly due to diabetic kidney disease or hypertensive nephrosclerosis. Here, XDH is linked to diabetic kidney disease.